These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12699912)

  • 1. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
    Gopee NV; Sharma RP
    Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and transient activation of protein kinase C alpha by fumonisin B1, a ceramide synthase inhibitor mycotoxin, in cultured porcine renal cells.
    Gopee NV; Sharma RP
    Life Sci; 2004 Feb; 74(12):1541-59. PubMed ID: 14729403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumonisin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-kappaB and tumor necrosis factor alpha in LLC-PK1 cells.
    Gopee NV; He Q; Sharma RP
    Chem Biol Interact; 2003 Oct; 146(2):131-45. PubMed ID: 14597127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
    Kim MS; Lee DY; Wang T; Schroeder JJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
    He Q; Riley RT; Sharma RP
    Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine.
    Yu CH; Lee YM; Yun YP; Yoo HS
    Arch Pharm Res; 2001 Apr; 24(2):136-43. PubMed ID: 11339633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
    Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
    Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
    Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells.
    Sharma N; He Q; Sharma RP
    Chem Biol Interact; 2004 Dec; 151(1):33-42. PubMed ID: 15607760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor alpha and caspase 3 via protein kinase Calpha-dependent pathway in porcine renal epithelial cells.
    Gopee NV; Sharma RP
    Cell Biol Toxicol; 2004 Jul; 20(4):197-212. PubMed ID: 15499968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture.
    Ramasamy S; Wang E; Hennig B; Merrill AH
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):343-8. PubMed ID: 7645031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
    Suzuki H; Riley RT; Sharma RP
    Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
    Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases.
    Smith ER; Jones PL; Boss JM; Merrill AH
    J Biol Chem; 1997 Feb; 272(9):5640-6. PubMed ID: 9038174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.